[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"newborn-health\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:newborn-health":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,46,78],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100642193","restrictions-on-maternity-ward-visits-current-situation-challenges-and-recommendations-in-the-auvergne-rhone-alpes-region-aura-100642193",false,"NCT07653646","Restrictions on Maternity Ward Visits: Current Situation, Challenges and Recommendations in the Auvergne Rhone-Alpes Region (AuRA)","Restrictions on Maternity Ward Visits: Current Situation, Challenges and Recommendations in the AuRA Region","VISIMAT","Inclusion Criteria:\n\n* Adult female patient (aged 18 or over),\n* Female patient admitted to the maternity ward with her newborn baby or babies,\n* Length of stay in the maternity ward of 48 hours or more,\n* Female patient who has been informed about the study and has given her free, informed verbal consent to participate in the study.\n\nExclusion Criteria:\n\n* Patients who have already participated in this study,\n* Patients whose newborn(s) are hospitalised in neonatal units, neonatal intensive care units or neonatal resuscitation units,\n* Patients who have given birth to three or more newborns (triplets or more),\n* Patient whose newborn(s) has\u002Fhave died,\n* Patient unable to understand spoken or written French, making self-assessment impossible,\n* Patient under guardianship, curatorship or placed under judicial protection,\n* Patient not covered by the French social security system.","FEMALE","18 Years",{"count":20,"type":21},8000,"ESTIMATED","INTERVENTIONAL",[24],"NA","Maternal mental health in the postpartum period is a major public health issue in France. The 2021 National Perinatal Survey highlights high prevalence rates of mental health disorders among mothers, with 27.6% experiencing anxiety disorders, 16.7% experiencing depressive disorders and 5.4% having suicidal thoughts. Between 2016 and 2018, suicide was also the leading cause of maternal mortality in the year following childbirth, underscoring the severity and frequency of these disorders. In response, international guidelines, notably those of the World health Organisation (WHO), as well as national policies such as the 'First 1,000 Days' strategy, emphasise the importance of early, enhanced and individualised postnatal support. In France, this postpartum care tends to be structured around the Early Postnatal Interview and the recommended use of validated screening tools such as the Edinburgh Postnatal Depression Scale (EPDS).\n\nHowever, the quality of postpartum care depends not only on screening and clinical follow-up, but also on organisational and environmental factors. Among these, the arrangements for maternity ward visits constitute a potential determinant of patients' experiences, likely to influence both their mental state, their rest, the establishment of breastfeeding and, indirectly, the health of the newborn. The exceptional measures implemented during the Covid-19 pandemic, notably the restriction of visits, have shown generally favourable effects, with improved satisfaction among patients and healthcare staff, better conditions for rest, facilitation of breastfeeding and a perceived improvement in working conditions.\n\nHowever, these data were collected in an exceptional health context, which may introduce biases linked to the social, emotional and organisational constraints specific to this period. Their extrapolation to routine practice therefore remains uncertain. Furthermore, in the absence of specific national guidelines governing maternity ward visits, the current regulatory framework remains unclear and practices vary between institutions, often relying on local decisions that have not been scientifically evaluated.\n\nAgainst this backdrop, the VISIMAT study aims to characterise maternity ward visiting arrangements outside of any exceptional circumstances and to assess their impact on the health of mothers and newborns, as well as on healthcare workers' working conditions. Its aim is to provide a scientific basis to inform the development of standardised recommendations and prevention messages.",[27,28],"Post Partum Women","Newborn Health",[30,31,32],"maternity wards visiting","mother health","newborn health","NOT_YET_RECRUITING","2026-06-16",{"date":36,"type":37},"2026-06-17","ACTUAL",{"date":39,"type":21},"2026-06-15",{"date":41,"type":21},"2028-06",{"name":43,"class":44},"Centre Hospitalier Annecy Genevois","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":53,"sex":17,"minAge":18,"maxAge":54,"enrollmentInfo":55,"targetDuration":4,"studyType":22,"phases":57,"briefSummary":58,"conditions":59,"keywords":66,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":45},"100614469","effect-of-a-respectful-maternity-care-based-action-plan-in-postpartum-care-on-maternal-and-neonatal-outcomes-100614469","NCT07280000","Effect of a Respectful Maternity Care-Based Action Plan in Postpartum Care on Maternal and Neonatal Outcomes","The Effect of the Action Plan Developed Within the Framework of Respectful Maternity Care in Postpartum Care on Maternal and Neonatal Outcomes","Inclusion Criteria:\n\n* Postpartum women aged 18 years and older\n* Gave birth at 37-42 gestational weeks (vaginal or cesarean)\n* Have a single, healthy newborn\n* No chronic medical conditions\n* No history of high-risk pregnancy or fetal complications\n* No communication barriers (e.g., visual or hearing impairment)\n* Able to speak and understand Turkish\n* Literate and able to read and write in Turkish\n\nExclusion Criteria:\n\n* Development of maternal or neonatal complications during the postpartum follow-up period\n* Inability to reach the mother at the 8-week postpartum follow-up",true,"49 Years",{"count":56,"type":21},500,[24],"This study will examine whether a Respectful Maternity Care-based action plan can improve the quality of postpartum care and maternal and newborn outcomes. Nurses and midwives will receive a three-day interactive training about respectful, evidence-based postpartum care. After training, a unit-level action plan will be implemented, including supportive visits, educational materials, and feedback meetings. Women receiving routine postpartum care before the intervention will be compared with women receiving care after implementation. Outcomes will include respectful maternity care experiences, maternal satisfaction, exclusive breastfeeding at 6-8 weeks, maternal mental health, mother-infant bonding, and postpartum complications. The goal of this study is to promote respectful, high-quality postpartum care and improve the health and well-being of mothers and newborns.",[60,61,28,62,63,64,65],"Postpartum Care","Maternal Health Care","Postpartum Depression (PPD)","Breastfeeding","Quality of Care","Maternal Satisfaction",[67,60,68,28],"Respectful Maternity Care","Maternal Health","2025-12-01",{"date":71,"type":37},"2025-12-12",{"date":73,"type":21},"2025-12-10",{"date":75,"type":21},"2026-12-01",{"name":77,"class":44},"ilayda sel",{"id":79,"slug":80,"hasResults":11,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":84,"eligibilityCriteria":85,"healthyVolunteers":53,"sex":17,"minAge":86,"maxAge":54,"enrollmentInfo":87,"targetDuration":4,"studyType":22,"phases":89,"briefSummary":91,"conditions":92,"keywords":98,"overallStatus":103,"whyStopped":4,"lastUpdateSubmitDate":104,"lastUpdatePostDateStruct":105,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":45},"100595194","phase-3-the-mom-care-trial--evaluating-antenatal-and-postnatal-mmsplus-for-improved-infant-birth-and-growth-outcomes-100595194","NCT07029282","The MOM-CARE Trial : Evaluating Antenatal and Postnatal MMSPlus for Improved Infant Birth and Growth Outcomes","A Phase III Double-Blind, Adaptive Randomized Trial of Antenatal MMSPlus Versus UNIMAPP MMS and Postnatal MMSPlus Versus UNIMAPP MMS or IFA to Improve Infant Birth Outcomes and Growth at 6 Months","MOM-CARE","Antenatal Phase::\n\nInclusion Criteria:\n\n* Gestational age confirmed by ultrasound to be 8-14 weeks\n* Singleton and viable fetus on ultrasound\n* A resident of the catchment area for at least the last six months\n* Plans to stay within the catchment area during the pregnancy duration, during delivery and after birth of the baby.\n* Has provided voluntary written informed consent\n\nExclusion Criteria:\n\n* Women with known allergies or intolerance to any components of the MMS or MMS PLUS being studied\n* Women with pre-existing health conditions such as history of uncontrolled diabetes and hypertension or other chronic illnesses\n* Substance abuse, such as recreational drugs or smoking tobacco. Women chewing tobacco will not be excluded.\n\nPostnatal Phase::\n\nInclusion Criteria:\n\n* Birth weight available within 72 hours\n* Intention to breastfeed for 6 months\n* Resides in the study area for the duration of the trial\n* Has provided voluntary written informed consent\n\nExclusion Criteria:\n\n* Congenital anomalies, birth defects, or severe neonatal complications\n* Infants who are already receiving supplemental formula feeding or other nutritional supplements (except pre-lacteal feeding, vitamins, and medications)\n* Infants whose mothers have conditions that significantly affect breastfeeding, such as severe postpartum depression, insufficient milk supply, or maternal use of medications that contraindicate breastfeeding","15 Years",{"count":88,"type":21},3000,[90],"PHASE3","This clinical trial aims to learn if MMS Plus improves infant health compared to standard MMS during pregnancy and the postnatal period in women living in peri-urban areas of Karachi, Pakistan. It will also evaluate how MMS Plus affects infant growth during the first 6 months of life.\n\nThe main questions it aims to answer are:\n\n1. Does MMS Plus during pregnancy reduce the risk of poor infant outcomes compared to standard MMS, as measured on a 5-point ordinal scale ranging from perinatal mortality to term birth with appropriate, small, or large-for-gestational-age infants?\n2. Does postnatal MMS Plus improve infant length velocity at 6 months of age among exclusively breastfed infants compared to standard MMS and iron\u002Ffolic acid (IFA) supplementation?\n\nResearchers will compare:\n\n1. MMS Plus versus standard MMS during pregnancy (antenatal phase)\n2. MMS Plus versus standard MMS versus IFA after birth (postnatal phase)\n\nParticipants will:\n\n1. Be randomly assigned to receive either MMS Plus or standard MMS during pregnancy\n2. Be re-randomized after delivery to receive either MMS Plus, standard MMS, or IFA supplements during the postnatal period\n3. Receive supplements under double-blind conditions\n4. Be followed through childbirth and until the infant is 6 months of age\n5. Attend regular clinic visits for health monitoring, infant assessments, and data collection.\n\nThis phase III adaptive randomized controlled trial will occur in three peri-urban catchment areas of Karachi, Pakistan.",[28,93,94,95,96,97],"Multiple Micronutrient Deficiencies During Pregnancy","Nutrition During Pregnancy","Adaptive Trial","Postnatal Growth","Neurodevelopment Outcome",[99,100,101,102],"Antenatal Phase","Postnatal Phase","Micro Nutrient Supplementation","Infant Growth","RECRUITING","2025-10-01",{"date":106,"type":37},"2025-10-07",{"date":108,"type":37},"2025-07-08",{"date":110,"type":21},"2027-12-31",{"name":112,"class":44},"Aga Khan University"]